| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020893038 |
| P356 | DOI | 10.1186/1471-2407-14-669 |
| P932 | PMC publication ID | 4176858 |
| P698 | PubMed publication ID | 25223755 |
| P5875 | ResearchGate publication ID | 265691757 |
| P50 | author | Rafał Pawliczak | Q9303037 |
| Piotr Rieske | Q59680077 | ||
| Joanna Peciak | Q87277963 | ||
| Marcin Pacholczyk | Q90616366 | ||
| Sylwester Piaskowski | Q114444374 | ||
| Ewelina Stoczynska-Fidelus | Q42323744 | ||
| Michał Bieńkowski | Q56085647 | ||
| Michał Rostkowski | Q57611575 | ||
| P2093 | author name string | Mateusz Banaszczyk | |
| Krystyna Hulas-Bigoszewska | |||
| Maciej Walczak | |||
| Jolanta Zieba | |||
| Malgorzata Szybka | |||
| Marta Winiecka-Klimek | |||
| P2860 | cites work | ViennaRNA Package 2.0 | Q24053233 |
| Identification of a novel p53 functional domain that is necessary for efficient growth suppression | Q24311276 | ||
| Kinetics of tetramolecular quadruplexes | Q24793427 | ||
| Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex | Q28242020 | ||
| The p53 codon 72 polymorphism and lung cancer risk | Q73112355 | ||
| A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas | Q73292171 | ||
| Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years | Q77858499 | ||
| p.R72P, PIN3 Ins16bp polymorphisms of TP53 and CCR5?32 in north Indian breast cancer patients | Q85003617 | ||
| Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. | Q30540705 | ||
| Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer | Q33317092 | ||
| cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer | Q33492556 | ||
| Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. | Q33931140 | ||
| Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies | Q34400583 | ||
| Tumor suppressor genes in normal and malignant hematopoiesis | Q34658581 | ||
| Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients | Q34769934 | ||
| TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure. | Q36288723 | ||
| Polymorphisms in the p53 pathway. | Q36426763 | ||
| p53 codon 72 polymorphism as a progression index for bladder cancer | Q36642834 | ||
| Co-transcriptional formation of DNA:RNA hybrid G-quadruplex and potential function as constitutional cis element for transcription control | Q36878520 | ||
| Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions | Q36978525 | ||
| DNA secondary structures: stability and function of G-quadruplex structures | Q37051064 | ||
| A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. | Q37073676 | ||
| How many mutant p53 molecules are needed to inactivate a tetramer? | Q37278142 | ||
| DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria | Q39540829 | ||
| Widespread monoallelic expression on human autosomes | Q40050793 | ||
| The codon 72 polymorphic variants of p53 have markedly different apoptotic potential | Q40672888 | ||
| The polyproline region of p53 is required to activate apoptosis but not growth arrest. | Q41093439 | ||
| The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies | Q41613728 | ||
| Detection of P53 mutations in different cancer types is improved by cDNA sequencing. | Q42323670 | ||
| DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. | Q44165063 | ||
| The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. | Q44258889 | ||
| p53 polymorphic variants at codon 72 exert different effects on cell cycle progression | Q44669574 | ||
| G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. | Q50533354 | ||
| A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. | Q54740167 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | haploinsufficiency | Q852654 |
| P304 | page(s) | 669 | |
| P577 | publication date | 2014-09-15 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | PIN3 duplication may be partially responsible for TP53 haploinsufficiency | |
| P478 | volume | 14 |
Search more.